搜索临床试验以:氨氯地平 2.5 毫克/阿托伐他汀 10 毫克
总计408个结果
-
Shin Poong Pharmaceutical Co. Ltd.完全的
-
University of PisaUniversity of Messina; University of Catania; Università degli Studi dell'Insubria尚未招聘
-
Paddock Laboratories, Inc.完全的
-
Zhujiang Hospital尚未招聘疗效终点:1年内无新的脑血管不良事件 | 安全终点:一年内没有新的中度或严重不良事件 | 全因死亡事件(一年内) | 缺血性中风事件(1年内) | 新的出血性中风事件(1年内) | 新支架血栓事件(1年内) | 新的症状性狭窄事件(1 年内) | 支架内狭窄的发生 第 12 ±1 个月年度血管造影随访 | 第 12 ±1 个月年度血管造影随访时的支架内狭窄程度(采用 WASID 方法测量) | 每年 12±1 个月血管造影随访时的目标动脉瘤栓塞率(Raymond 和 OKM 分类)
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完全的
-
Tanta UniversityEman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Fedaa Abd El-monem Kamal El-deen... 和其他合作者招聘中
-
Hanscom, Thomas, M.D.Genentech, Inc.完全的视网膜中央静脉阻塞 | 黄斑水肿 | 视网膜分支静脉阻塞美国
-
Yonsei University完全的
-
Monash UniversityNational Health and Medical Research Council, Australia招聘中
-
University of Kansas Medical CenterEli Lilly and Company; Kowa Pharmaceuticals America, Inc.完全的
-
Northwestern UniversityNational Institutes of Health (NIH); Northwestern Medical Group撤销
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul Cancro完全的
-
Postgraduate Institute of Medical Education and...未知
-
Nanfang Hospital of Southern Medical UniversityMajor Science and Technology Special Project of China 12th Five-year未知
-
The George InstituteUniversity of Sydney终止
-
Arizona State UniversityNational Institute on Drug Abuse (NIDA); Pfizer; University of Nevada, Reno; Los Angeles Clinical...完全的
-
U.S. Army Medical Research and Development CommandSmithKline Beecham完全的
-
National Heart Foundation of BangladeshJohns Hopkins University; National Heart Foundation Hospital and Research Institute of Bangladesh 和其他合作者完全的